GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Thoratec Corporation (THOR) [hlAlert]

Rating:
Equal Weight
THOR
up 45.12 %

Thoratec Corporation (THOR) rated Equal Weight with price target $28 by Barclays

Posted on: Tuesday,  Oct 28, 2014  2:25 PM ET by Barclays

Barclays rated Equal Weight Thoratec Corporation (NASDAQ: THOR) on 10/28/2014. Previously Barclays rated Overweight Thoratec Corporation (NASDAQ: THOR) on 10/31/2013.,
when the stock price was $42.99. Since then, Thoratec Corporation has gained 45.13% as of 08/27/2015's recent price of $62.39.
If you would have followed the previous Barclays's recommendation on THOR, you would have gained 45.12% of your investment in 665 days.

Thoratec Corporation (Thoratec) is a manufacturer of mechanical circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets medical devices used for circulatory support. It also develops, manufactures and markets point-of-care diagnostic test systems and skin incision products. Thoratec operates in two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. The Company conducts business both in the United States and internationally.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/28/2014 2:25 PM Buy
None
26.23 28.00
as of 10/17/2014
1 Week down  -1.26 %
1 Month down  -1.72 %
3 Months down  -21.06 %
1 YTD down  -29.78 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2013 1:25 PM Buy
None
42.99 45.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy